Mark Oldroyd brings nearly 30 years of healthcare industry experience as Chief Commercial Officer at Culmination.

He also serves on the board of directors at multiple startup companies. His career has focused on commercialization in startup organizations with assets in therapeutics, diagnostics, equipment, and devices.

Before Culmination, he served as Chief Business Officer at C2i Genomics. Mr. Oldroyd has provided advisory services to many small companies and still coaches stealth-stage startups at Lionbird, a venture fund in Israel. He is formally trained in law with a specialty in health policy.

Mr. Oldroyd enjoys his downtime exploring remote areas of the western US as a private pilot or on an adventure motorcylce. He has five adult children and two grandsons.